Home > Archive>Volume 15, Issue 1, 2022 >65-70. DOI:10.18240/ijo.2022.01.10
PDF HTML XML Export Cite reminder
Effectiveness of surgical management of malignant glaucoma in phakic eyes
Author:
Corresponding Author:

Wei-Rong Chen and Hao-Tian Lin. Zhongshan Ophthalmic Center, Xian Lie South Road #54, Guangzhou 510060, Guangdong Province, China. chenwr_q@aliyun.com; haot.lin@hotmail.com

Fund Project:

Supported by the National Natural Science Foundation of China (No.81700812).

  • Article
    • | |
  • Metrics
    • |
  • Reference [30]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    AIM: To assess the effectiveness of core vitrectomy-phacoemulsification-intraocular lens (IOL) implantation-capsulo-hyaloidotomy in treating phakic eye at least 1mo after the onset of malignant glaucoma. METHODS: A retrospective analysis were performed on malignant glaucoma patients treated in Zhongshan Ophthalmic Center between 2016 and 2018. Demographic and clinical data were described. The preoperative and postoperative visual acuity (VA), intraocular pressure (IOP), number of IOP-lowering medications used, and anterior chamber depth (ACD) of the case series were compared by Wilcoxon signed-rank test. RESULTS: Thirteen phakic eyes with long time intervals between onset and surgery were identified in this case series. Core vitrectomy-phacoemulsification-IOL implantation-capsulo-hyaloidotomy reduced the IOP (P=0.046) and the number of IOP-lowering medications used (P=0.004), deepened the ACD (P=0.005). Complete success was achieved in 38.5% of the eyes, and anatomical success was achieved in 100% of the eyes without any recurrence. The only postoperative complication observed is corneal endothelial decompensation. It occurred in two cases. CONCLUSION: Core vitrectomy-phacoemulsification-IOL implantation-capsulo-hyaloidotomy is safe and effective for treatment of long onset phakic malignant glaucoma.

    Reference
    1 Luntz MH, Rosenblatt M. Malignant glaucoma. Surv Ophthalmol 1987;32(2):73-93.
    2 Trope GE, Pavlin CJ, Bau A, Baumal CR, Foster FS. Malignant glaucoma. Clinical and ultrasound biomicroscopic features. Ophthalmology 1994;101(6):1030-1035.
    3 Dave P, Senthil S, Rao HL, Garudadri CS. Treatment outcomes in malignant glaucoma. Ophthalmology 2013;120(5):984-990.
    4 Shahid H, Salmon JF. Malignant glaucoma: a review of the modern literature. J Ophthalmol 2012;2012:852659.
    5 Quigley HA, Friedman DS, Congdon NG. Possible mechanisms of primary angle-closure and malignant glaucoma. J Glaucoma 2003;12(2):167-180.
    6 Wang ZH, Huang JJ, Lin JL, Liang XW, Cai XY, Ge J. Quantitative measurements of the ciliary body in eyes with malignant glaucoma after trabeculectomy using ultrasound biomicroscopy. Ophthalmology 2014;121(4):862-869.
    7 Teichmann K. Aqueous misdirection syndrome is not actually caused by aqueous misdirection. J Glaucoma 2003;12(2):184; author reply 184; author reply 185.
    8 Chen XX, Guo XX, Xu XY, Xiao H, Liu X. Is thicker choroid a risk factor for malignant glaucoma? Ophthalmic Res 2018;60(3):161-168.
    9 Prata TS, Dorairaj S, De Moraes CG, Mehta S, Sbeity Z, Tello C, Liebmann J, Ritch R. Is preoperative ciliary body and iris anatomical configuration a predictor of malignant glaucoma development? Clin Exp Ophthalmol 2013;41(6):541-545.
    10 Hodes BL. Malignant glaucoma after laser iridotomy. Ophthalmology 1992;99(11):1641-1642.
    11 He F, Qian Z, Lu L, Jiang J, Fan X, Wang Z, Xu X. Clinical efficacy of modified partial pars plana vitrectomy combined with phacoemulsification for malignant glaucoma. Eye (Lond) 2016;30(8):1094-1100.
    12 Dervenis N, Mikropoulou AM, Dervenis P, Lewis A. Anterior segment approach for the surgical management of aqueous misdirection syndrome. J Cataract Refract Surg 2017;43(7):877-878.
    13 Zhou C, Qian S, Yao J, Tang Y, Qian J, Lu Y, Xu G, Sun X. Clinical analysis of 50 Chinese patients with aqueous misdirection syndrome: a retrospective hospital-based study. J Int Med Res 2012;40(4):1568-1579.
    14 Al Bin Ali GY, Al-Mahmood AM, Khandekar R, Abboud EB, Edward DP, Kozak I. Outcomes of pars plana vitrectomy in the management of refractory aqueous misdirection syndrome. Retina 2017;37(10): 1916-1922.
    15 Kirchhof B. The contribution of vitreoretinal surgery to the management of refractory glaucomas. Curr Opin Ophthalmol 1999;10(2):117-120.
    16 Chaudhry NA, Flynn HW Jr, Murray TG, Nicholson D, Palmberg PF. Pars plana vitrectomy during cataract surgery for prevention of aqueous misdirection in high-risk fellow eyes. Am J Ophthalmol 2000;129(3):387-388.
    17 Foreman-Larkin J, Netland PA, Salim S. Clinical management of malignant glaucoma. J Ophthalmol 2015;2015:283707.
    18 Zhao YE, Gong XH, Zhu XN, Li HM, Tu MJ, Coursey TG, Pflugfelder SC, Gu F, Chen D. Long-term outcomes of ciliary sulcus versus capsular bag fixation of intraocular lenses in children: an ultrasound biomicroscopy study. PLoS One 2017;12(3):e0172979.
    19 Garza-Leon M. Corneal endothelial cell analysis using two non-contact specular microscopes in healthy subjects. Int Ophthalmol 2016;36(4):453-461.
    20 Teichmann K, Quigley HA. Malignant glaucoma, an enigma solved? J Glaucoma 2003;12(5):446-447; author reply 447-448.
    21 Kaplowitz K, Yung E, Flynn R, Tsai JC. Current concepts in the treatment of vitreous block, also known as aqueous misdirection. Surv Ophthalmol 2015;60(3):229-241.
    22 Grzybowski A, Kanclerz P. Acute and chronic fluid misdirection syndrome: pathophysiology and treatment. Graefes Arch Clin Exp Ophthalmol 2018;256(1):135-154.
    23 Mardelli PG, Mardelli ME. Slit-lamp needling of the anterior capsule for aqueous misdirection after hyaloido-zonulectomy and iridectomy. J Glaucoma 2018;27(4):e77-e79.
    24 Kr?p?t? L, ?emaitien? R, Miliauskas A. Clinical characteristics and outcomes of malignant glaucoma after different procedures treated with pars plana vitrectomy: a 10-year retrospective study. Medicina (Kaunas) 2018;54(4):E65.
    25 Schwab C, Glatz W, Schmidt B, Lindner E, Oettl K, Riedl R, Wedrich A, Ivastinovic D, Velikay-Parel M, Mossboeck G. Prevalence of posterior vitreous detachment in glaucoma patients and controls. Acta Ophthalmol 2017;95(3):276-280.
    26 Sebag J. Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol 1987;225(2):89-93.
    27 Sharma A, Sii F, Shah P, Kirkby GR. Vitrectomy-phacoemulsification-vitrectomy for the management of aqueous misdirection syndromes in phakic eyes. Ophthalmology 2006;113(11):1968-1973.
    28 Debrouwere V, Stalmans P, van Calster J, Spileers W, Zeyen T, Stalmans I. Outcomes of different management options for malignant glaucoma: a retrospective study. Graefes Arch Clin Exp Ophthalmol 2012;250(1):131-141.
    29 Tang JF, Du EG, Li XY. Combined surgical techniques for the management of malignant glaucoma. J Ophthalmol 2018;2018:9189585.
    30 Balekudaru S, Choudhari NS, Rewri P, George R, Bhende PS, Bhende M, Lingam V, Lingam G. Surgical management of malignant glaucoma: a retrospective analysis of fifty eight eyes. Eye (Lond) 2017;31(6):947-955.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Qi-Wei Wang, Jing Li, Xiao-Shan Lin,/et al.Effectiveness of surgical management of malignant glaucoma in phakic eyes. Int J Ophthalmol, 2022,15(1):65-70

Copy
Share
Article Metrics
  • Abstract:740
  • PDF: 827
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:March 31,2021
  • Revised:October 08,2021
  • Online: December 24,2021
You are the 4402933 Visitors
Governing Body：Department of Health, Provincial Government of Shaanxi, China
Organizer：Xi'an Medical Association of China
Address：Room 11707-08, Building 2, Unit 1, Wanda Plaza, No.8 Yanta North Road, Xi'an 710054, Shaanxi Province, China
Fax：(8629)82245172 Phone：(+8629)82245172/82210956
Email：ijopress@163.com
International Journal of Ophthalmology ® 2025 All Rights Reserved   The terms of CC BY-NC-ND 4.0 are applicable to all open access content.